EP2143369A1 — Capsule-type medical system
Assigned to Olympus Corp · Expires 2010-01-13 · 16y expired
What this patent protects
A capsular medical system includes a capsular in-body unit having a radio transmitting device and an extracorporeal device. The extracorporeal device includes a ratio receiving device in the extracorporeal device, to which a plurality of antennas are connected, a switching device…
USPTO Abstract
A capsular medical system includes a capsular in-body unit having a radio transmitting device and an extracorporeal device. The extracorporeal device includes a ratio receiving device in the extracorporeal device, to which a plurality of antennas are connected, a switching device which switches the plurality of antennas, and a monitor device which monitors a receiving state of the selected antenna. The monitor device includes a device for measuring the data amount of medical data in units transmitted from the in-body unit, a device which counts a time required for transmitting the medical data in units from the in-body unit, and a calculating device which calculates a data transfer speed based on the data amount and the time required for transmitting the data.
Drugs covered by this patent
- Abilify (aripiprazole) · Generic (originally Otsuka/BMS)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.